top of page
Image by Mari Ganesh Kumar

2019 Annual Conference

Next-Generation Antibodies Therapeutics: Discovery, Development, and Beyond

April 7, 2019

Boston Marriott Cambridge

Speakers

Fubao Wang

Vice President, Regulatory CMC, Sarepta Therapeutics

Zhidan Tu

Director, Legend Biotech

Kerry Chester

Professor, UCL Cancer Institute; The Antibody Society

Chengbin Wu

Founder and CEO, EpimAb Biotherapeutics

Yan Wu

Director, Genentech

Tariq Ghayur

Senior Principal Scientist & Research Fellow, Abbvie

Scott Liu

Co-founder, President & CEO, Henlius

Yongjun Liu

Global Head of Research, Senior Vice President R&D, Sanofi

John (Jack) Prior

Head, Manufacturing Science, Sanofi Genzyme

Gang Chen

Vice President, Regeneron

Shouye Wang

Director of CMC Management, Wuxi Biologics

Nils Lonberg

Senior Vice President, Bristol Myers Squibb

Mitchell Ho

Senior Investigator, National Cancer Institute

Changshou Gao

Senior Director & Fellow, MedImmune

Patrick A. Baeuerle

Executive Partner, MPM Capital

Ira Pastan

Distinguished Investigator, NIH

Jingsong Wang

Chairman & CEO, Harbour BioMed

Steve Lee

Chief Executive Officer & Founder, BioGENEXUS LLC

Chun Zhang

SVP, Head of Technical Operations, Evelo Bioscience

Christopher Hwang

Chief Technology Officer, Transcenta

03-24-2019-booth banner-60x92 inch.png
bottom of page